Nebsadual

Ahlcon Parenterals (India) Limited🇵🇭 Food and Drug Administration - Philippines

Approval Id: 13026e10b9abc183
Drug Approval Philippines Name: Nebsadual
Product Name: Nebsadual
Registration Number: DRP-13048-07
Brand Name: Nebsadual
Generic Name: Salbutamol (as sulfate) + Ipratropium bromide
Dosage Form: Solution for Inhalation
Dosage Strength: 2.5 mg/500 mcg per 2.5 mL
Manufacturer: Ahlcon Parenterals (India) Limited
Importer: Ambicare Pharmaceuticals Inc
Distributor: Diafarm, Inc.
Issuance Date: 29 November 2024
Expiry Date: 24 November 2027
Pharmacologic Category: Selective beta-2-adrenoreceptor agonist/Anticholinergic
Classification: Prescription Drug (Rx)

Approved

Agency

Philippines FDA

Country

🇵🇭

Approval Date

Jul 14, 2025

Approval ID

13026e10b9abc183

Type

Standard